Relay Therapeutics Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Relay Therapeutics Inc had 204.59M in cash and cash equivalents.

Relay Therapeutics Inc reported 54.27M in total liabilities as of the latest reported quarter, including 25.58M in current liabilities and 28.69M in non-current liabilities.

As of the latest reported quarter, Relay Therapeutics Inc's total assets were 621.33M, consisting of 578.28M in current assets and 43.05M in non-current assets.

Relay Therapeutics Inc reported 567.06M in total shareholders' equity as of the latest reported quarter.